OppenheimerFunds’s Arena Pharmaceuticals Inc ARNA Stock Holding History

OppenheimerFunds’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-700,000	Closed	-$32.5M	–	993
2015 Q2	$32.5M	Hold	700,000	–	–	0.04%	459
2015 Q1	$30.6M	Hold	700,000	–	–	0.03%	491
2014 Q4	$24.3M	Hold	700,000	–	–	0.03%	545
2014 Q3	$29.3M	Hold	700,000	–	–	0.03%	475
2014 Q2	$41M	Hold	700,000	–	–	0.05%	395
2014 Q1	$44.1M	Buy	700,000 +100,000	+17%	+$6.63M	0.05%	369
2013 Q4	$35.1M	Sell	600,000 -600,000	-50%	-$31.4M	0.04%	422
2013 Q3	$63.2M	Buy	1,200,000 +600,000	+100%	+$40.3M	0.04%	422
2013 Q2	$46.2M	Buy	+600,000	New	+$49M	0.07%	329

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

OppenheimerFunds's ARNA Position: Q3 2015 in Review

OppenheimerFunds sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2015, closing a stake of 700,000 shares — an estimated $32.5M sold.

OppenheimerFunds first reported a position in ARNA in Q2 2013 and held it in 9 quarters. The position peaked at $63.2M in Q3 2013. 120 funds tracked by Wall St. Rank hold ARNA as of Q3 2015.

OppenheimerFunds reported no remaining Arena Pharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
OppenheimerFunds sold 700,000 Arena Pharmaceuticals Inc shares in Q3 2015, an estimated $32.5M.
OppenheimerFunds first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 9 quarters.
OppenheimerFunds's Arena Pharmaceuticals Inc position peaked at $63.2M in Q3 2013.
120 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2015.

Based on OppenheimerFunds's 13F filing for Q3 2015, filed 6 Nov 2015.